Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117103) titled 'Clinical Development and Application Research of a Novel Bone Turnover Marker Based on Original Collagen Active Peptides' on Jan. 20.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The Second Xiangya Hospital of Central South University
Condition:
Osteoporosis
Intervention:
The osteoporosis group:None
The osteopenia group:None
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-01-20
Target Sample Size: The osteoporosis group:1200;The osteopenia group:2400;The normal group:5900;
Countries of Recruitment:
China
To know more...